Гипертонический солевой раствор 7%, 25 стерильных пуль по 5 мл

Hypertonic Saline 7% enhances mucus clearance and improves lung function. It is effective for treating moderate and severe lung diseases, including cystic fibrosis. This saline solution increases airway surface liquid volume, restores mucus clearance, and eases expectoration, ultimately improving the quality of life and reducing hospital admissions.

Hypertonic Saline 7% is administered via inhalation using a nebulizer. Each package contains 25 single-use containers with 5ml of sterile saline solution, suitable for effective respiratory therapy as prescribed by healthcare professionals.

Yes, Hypertonic Saline 7% is considered safe for long-term use under medical supervision. Its safety and efficacy make it a valuable treatment option for enhancing lung function and reducing mucus viscosity in chronic lung conditions.

The Hypertonic Saline 7% product from NavePharma has expiration dates of 07/10/2024 and 07/2025, ensuring you receive a product that maintains its stability and effectiveness throughout its shelf life.

Hypertonic Saline 7% is beneficial for individuals suffering from cystic fibrosis and other lung diseases that require increased mucus clearance and improved lung function. Patients should consult with their healthcare provider to determine if this treatment is appropriate for their condition.